Gsa Capital Partners LLP Amneal Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

$1.43 Billion
Q2 2025

A detailed history of Gsa Capital Partners LLP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 36,882 shares of AMRX stock, worth $360,705. This represents 0.02% of its overall portfolio holdings.

Number of Shares

36,882

Previous 70,414 47.62%

Holding current value

$360,705

Previous $590,000 49.49%

% of portfolio

0.02%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	SELL	$6.97 - $8.23 $233,718 - $275,968	-33,532 Reduced 47.62%	36,882 $298,000
Q1 2025 May 08, 2025	SELL	$7.72 - $9.01 $13,023 - $15,199	-1,687 Reduced 2.34%	70,414 $590,000
Q4 2024 Feb 07, 2025	BUY	$7.69 - $9.25 $136,505 - $164,196	17,751 Added 32.66%	72,101 $571,000
Q3 2024 Nov 05, 2024	SELL	$6.42 - $8.83 $644,632 - $886,620	-100,410 Reduced 64.88%	54,350 $452,000
Q2 2024 Aug 15, 2024	SELL	$5.36 - $7.11 $151,162 - $200,516	-28,202 Reduced 15.41%	154,760 $983,000
Q1 2024 May 03, 2024	BUY	$5.24 - $6.34 $958,720 - $1.16 Million	182,962 New	182,962 $1.11 Million
Q3 2023 Nov 15, 2023	SELL	$2.76 - $4.59 $251,891 - $418,906	-91,265 Reduced 79.88%	22,986 $97,000
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $44,863 - $104,569	33,732 Added 41.89%	114,251 $354,000
Q1 2023 May 12, 2023	SELL	$1.27 - $2.7 $120,053 - $255,231	-94,530 Reduced 54.0%	80,519 $111,000
Q4 2022 Feb 13, 2023	BUY	$1.96 - $2.61 $343,096 - $456,877	175,049 New	175,049 $348,000
Q2 2022 Aug 09, 2022	BUY	$3.01 - $4.46 $132,111 - $195,753	43,891 Added 40.65%	151,865 $483,000
Q1 2022 May 11, 2022	BUY	$3.9 - $4.89 $290,830 - $364,657	74,572 Added 223.26%	107,974 $450,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $131,937 - $195,401	33,402 New	33,402 $160,000
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $479,271 - $627,168	-111,200 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$5.12 - $6.82 $442,024 - $588,791	86,333 Added 347.18%	111,200 $569,000
Q1 2021 May 10, 2021	SELL	$4.74 - $7.38 $69,606 - $108,375	-14,685 Reduced 37.13%	24,867 $167,000
Q4 2020 Feb 03, 2021	SELL	$3.95 - $5.42 $56,532 - $77,571	-14,312 Reduced 26.57%	39,552 $181,000
Q3 2020 Nov 06, 2020	BUY	$3.54 - $5.27 $14,029 - $20,885	3,963 Added 7.94%	53,864 $209,000
Q2 2020 Aug 11, 2020	SELL	$2.87 - $5.46 $138,730 - $263,925	-48,338 Reduced 49.2%	49,901 $238,000
Q1 2020 May 12, 2020	BUY	$2.46 - $5.35 $241,667 - $525,578	98,239 New	98,239 $342,000
Q3 2019 Nov 12, 2019	SELL	$2.29 - $7.1 $117,394 - $363,974	-51,264 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$6.44 - $14.29 $330,140 - $732,562	51,264 New	51,264 $368,000
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $205,861 - $257,370	-17,343 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$13.09 - $21.49 $227,019 - $372,701	17,343 New	17,343 $235,000

Others Institutions Holding AMRX

# of Institutions

249

Shares Held

145M

Call Options Held

194K

Put Options Held

49.3K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.48B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Amneal Pharmaceuticals, Inc. Transaction History